文献リスト

1）Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev. 2007; 28(1): 84-116

2）Kawamori D, Welters HJ, Kulkarni RN. Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction. Adv Exp Med Biol. 2010; 654: 421-45

3）Unger RH. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism. 1978; 27(11): 1691-709

4）Gerich JE, Langlois M, Noacco C, et al. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science. 1973; 182(108): 171-3

5）Gelling RW, Du XQ, Dichmann DS, et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A. 2003; 100(3): 1438-43

6）Conarello SL, Jiang G, Mu J, et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia. 2007; 50(1): 142-50

7）Lee Y, Wang MY, Du XQ, et al. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes. 2011; 60(2): 391-7

8）Unger RH, Cherrington AD. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest. 2012; 122(1): 4-12

9）Bonner-Weir S, Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982; 31(10): 883-9

10）Stagner JI, Samols E. Retrograde perfusion as a model for testing the relative effects of glucose versus insulin on the A cell. J Clin Invest. 1986; 77(3): 1034-7

11）Cabrera O, Berman DM, Kenyon NS, et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A. 2006; 103(7): 2334-9

12）Bonner-Weir S, OBrien TD. Islets in type 2 diabetes: in honor of Dr. Robert C. Turner. Diabetes. 2008; 57(11): 2899-904

13）Bosco D, Armanet M, Morel P, et al. Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes. 2010; 59(5): 1202-10

14）Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011; 17(11): 1481-9

15）Rodriguez-Diaz R, Dando R, Jacques-Silva MC, et al. Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med. 2011; 17(7): 888-92

16）Watada H, Kajimoto Y, Miyagawa J, et al. PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes. 1996; 45(12): 1826-31

17）Thorel F, Nepote V, Avril I, et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature. 2010; 464(7292): 1149-54

18）Yang YP, Thorel F, Boyer DF, et al. Context-specific alpha- to-beta-cell reprogramming by forced Pdx1 expression. Genes Dev. 2011; 25(16): 1680-5

19）Orci L, Baetens D, Rufener C, et al. Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A. 1976; 73(4): 1338-42

20）Yoon KH, Ko SH, Cho JH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003; 88(5): 2300-8

21）Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia. 1983; 24(5): 366-71

22）Thorel F, Damond N, Chera S, et al. Normal glucagon signaling and beta-cell function after near-total alpha-cell ablation in adult mice. Diabetes. 2011; 60(11): 2872-82

23）Gerich JE, Charles MA, Grodsky GM. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest. 1974; 54(4): 833-41

24）Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes. 2005; 54(6): 1789-97

25）Vieira E, Salehi A, Gylfe E. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia. 2007; 50(2): 370-9

26）Franklin I, Gromada J, Gjinovci A, et al. Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes. 2005; 54(6): 1808-15

27）Olsen HL, Theander S, Bokvist K, et al. Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells. Endocrinology. 2005; 146(11): 4861-70

28）Salehi A, Vieira E, Gylfe E. Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes. 2006; 55(8): 2318-23

29）Meier JJ, Kjems LL, Veldhuis JD, et al. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes. 2006; 55(4): 1051-6

30）Rocha DM, Faloona GR, Unger RH. Glucagon-stimulating activity of 20 amino acids in dogs. J Clin Invest. 1972; 51(9): 2346-51

31）Muller WA, Faloona GR, Aguilar-Parada E, et al. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970; 283(3): 109-15

32）Yamada H, Otsuka M, Hayashi M, et al. Ca2+-dependent exocytosis of L-glutamate by alphaTC6, clonal mouse pancreatic alpha-cells. Diabetes. 2001; 50(5): 1012-20

33）Cabrera O, Jacques-Silva MC, Speier S, et al. Glutamate is a positive autocrine signal for glucagon release. Cell Metab. 2008; 7(6): 545-54

34）Gerich JE, Langlois M, Schneider V, et al. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. J Clin Invest. 1974; 53(5): 1284-9

35）Goberna R, Tamarit J Jr, Osorio J, et al. Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res. 1974; 6(4): 256-60

36）Gerich JE, Karam JH, Forsham PH. Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab. 1973; 37(3): 479-81

37）Iversen J. Effect of acetyl choline on the secretion of glucagon and insulin from the isolated, perfused canine pancreas. Diabetes. 1973; 22(5): 381-7

38）Ahren B. Autonomic regulation of islet hormone secretion--implications for health and disease. Diabetologia. 2000; 43(4): 393-410

39）Borg WP, Sherwin RS, During MJ, et al. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 1995; 44(2): 180-4

40）McCrimmon RJ, Fan X, Ding Y, et al. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes. 2004; 53(8): 1953-8

41）Evans ML, McCrimmon RJ, Flanagan DE, et al. Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes. 2004; 53(10): 2542-51

42）Weir GC, Knowlton SD, Atkins RF, et al. Glucagon secretion from the perfused pancreas of streptozotocin-treated rats. Diabetes. 1976; 25(4): 275-82

43）Asplin CM, Paquette TL, Palmer JP. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man. J Clin Invest. 1981; 68(1): 314-8

44）Maruyama H, Hisatomi A, Orci L, et al. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984; 74(6): 2296-9

45）Kawamori D, Kurpad AJ, Hu J, et al. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab. 2009; 9(4): 350-61

46）Rorsman P, Berggren PO, Bokvist K, et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature. 1989; 341(6239): 233-6

47）Xu E, Kumar M, Zhang Y, et al. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab. 2006; 3(1): 47-58

48）Ishihara H, Maechler P, Gjinovci A, et al. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol. 2003; 5(4): 330-5

49）Zhou H, Tran PO, Yang S, et al. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the “switch-off” hypothesis. Diabetes. 2004; 53(6): 1482-7

50）Hope KM, Tran PO, Zhou H, et al. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the “switch-off” hypothesis. Diabetes. 2004; 53(6): 1488-95

51）Kawamori D, Akiyama M, Hu J, et al. Growth factor signalling in the regulation of alpha-cell fate. Diabetes Obes Metab. 2011; 13 Suppl 1: 21-30

52）Greenbaum CJ, Havel PJ, Taborsky GJ Jr, et al. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. J Clin Invest. 1991; 88(3): 767-73

53）Cooperberg BA, Cryer PE. Insulin reciprocally regulates glucagon secretion in humans. Diabetes. 2010; 59(11): 2936-40

54）Gunton JE, Kulkarni RN, Yim S, et al. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell. 2005; 122(3): 337-49

55）Tornehave D, Kristensen P, Romer J, et al. Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem. 2008; 56(9): 841-51

56）Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes. 1997; 46(5): 785-91

57）de Heer J, Rasmussen C, Coy DH, et al. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia. 2008; 51(12): 2263-70

58）Creutzfeldt WO, Kleine N, Willms B, et al. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Diabetes Care. 1996; 19(6): 580-6

59）Foley JE, Ligueros-Saylan M, He YL, et al. Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes. Horm Metab Res. 2008; 40(10): 727-30

60）De Marinis YZ, Salehi A, Ward CE, et al. GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 2010; 11(6): 543-53

61）Shah P, Vella A, Basu A, et al. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000; 85(11): 4053-9

62）Holst JJ, Vilsboll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol. 2009; 297(1-2): 127-36

63）Shichiri M, Kawamori R, Abe H. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes. 1979; 28(4): 272-5

64）Kawamori R, Shichiri M, Kikuchi M, et al. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Diabetes. 1980; 29(9): 762-5

65）Katsura M, Kawamori R, Yamasaki Y, et al. Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics. Diabetes Res Clin Pract. 1993; 20(2): 93-100

66）Mitrakou A, Kelley D, Mokan M, et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med. 1992; 326(1): 22-9

67）Kalkhoff RK, Gossain VV, Matute ML. Plasma glucagon in obesity. Response to arginine, glucose and protein administration. N Engl J Med. 1973; 289(9): 465-7

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp